Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide HFA in Perennial Allergic Rhinitis
NCT00953147Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Aug 2009
- Primary completion
- Jan 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ciclesonide in perennial allergic rhinitis (PAR), sponsored by Sumitomo Pharma America. Started Aug 2009; status: completed.
02
Drugs
ciclesonide
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00953147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00953147.